These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22459665)

  • 1. Effects of influenza antivirals on individual and population immunity over many epidemic waves.
    Pepin KM; Riley S; Grenfell BT
    Epidemiol Infect; 2013 Feb; 141(2):366-76. PubMed ID: 22459665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling study.
    Leung K; Lipsitch M; Yuen KY; Wu JT
    Lancet Infect Dis; 2017 Mar; 17(3):339-347. PubMed ID: 27914853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative analysis of the level of cross-protection between epidemic waves of the 1918-1919 influenza pandemic.
    Rios-Doria D; Chowell G
    J Theor Biol; 2009 Dec; 261(4):584-92. PubMed ID: 19703472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral resistance and the control of pandemic influenza.
    Lipsitch M; Cohen T; Murray M; Levin BR
    PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of Antiviral Allocation Scheme for Pandemic Influenza Depends on Strain Transmissibility, Delivery Delay and Stockpile Size.
    Lydeamore M; Bean N; Black AJ; Ross JV
    Bull Math Biol; 2016 Feb; 78(2):293-321. PubMed ID: 26846916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating antiviral effectiveness against pandemic influenza using household data.
    Glass K; Becker NG
    J R Soc Interface; 2009 Aug; 6(37):695-703. PubMed ID: 19064345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.
    Moss R; McCaw JM; McVernon J
    PLoS One; 2011 Feb; 6(2):e14505. PubMed ID: 21346794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-prioritized use of antivirals during an influenza pandemic.
    Merler S; Ajelli M; Rizzo C
    BMC Infect Dis; 2009 Jul; 9():117. PubMed ID: 19638194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic.
    Goldstein E; Miller JC; O'Hagan JJ; Lipsitch M
    Influenza Other Respir Viruses; 2010 Mar; 4(2):101-12. PubMed ID: 20167050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of travel in the presence of cross-immunity may act to decrease the chance of a global pandemic.
    Thompson RN; Thompson CP; Pelerman O; Gupta S; Obolski U
    Philos Trans R Soc Lond B Biol Sci; 2019 Jun; 374(1775):20180274. PubMed ID: 31056047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
    Stilianakis NI; Perelson AS; Hayden FG
    J Infect Dis; 1998 Apr; 177(4):863-73. PubMed ID: 9534957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can treatment increase the epidemic size?
    Xiao Y; Brauer F; Moghadas SM
    J Math Biol; 2016 Jan; 72(1-2):343-61. PubMed ID: 25925242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Allocation of Vaccine and Antiviral Drugs for Influenza Containment over Delayed Multiscale Epidemic Model considering Time-Dependent Transmission Rate.
    Abbasi Z; Zamani I; Amiri Mehra AH; Ibeas A; Shafieirad M
    Comput Math Methods Med; 2021; 2021():4348910. PubMed ID: 34707682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study.
    Ghosh S; Heffernan J
    PLoS One; 2010 Dec; 5(12):e14307. PubMed ID: 21187938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.
    Kwok KO; Riley S; Perera RAPM; Wei VWI; Wu P; Wei L; Chu DKW; Barr IG; Malik Peiris JS; Cowling BJ
    BMC Infect Dis; 2017 May; 17(1):337. PubMed ID: 28494805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of the emergence of new successful viral strains in seasonal influenza.
    Omori R; Sasaki A
    J Theor Biol; 2013 Jul; 329():32-8. PubMed ID: 23567650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility.
    Balcan D; Hu H; Goncalves B; Bajardi P; Poletto C; Ramasco JJ; Paolotti D; Perra N; Tizzoni M; Van den Broeck W; Colizza V; Vespignani A
    BMC Med; 2009 Sep; 7():45. PubMed ID: 19744314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for mitigating an influenza pandemic.
    Ferguson NM; Cummings DA; Fraser C; Cajka JC; Cooley PC; Burke DS
    Nature; 2006 Jul; 442(7101):448-52. PubMed ID: 16642006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.